Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Trigen identifies new antithrombotic compounds

Nov. 27, 2003

Arixtra receives European approval for extended prophylaxis of VTE

Nov. 21, 2003

Twelve-month data favor transition to bivalirudin as standard treatment

Nov. 21, 2003

Novel factor Xa inhibitors prepared and tested at Merck KGaA

Nov. 18, 2003

Tanabe Seiyaku scientists design novel factor Xa inhibitors

Nov. 17, 2003

Lilly presents new factor Xa inhibitors

Nov. 14, 2003

Antithrombotic efficacy of the PAR-1 antagonist E-5555 in guinea pigs

Nov. 14, 2003

Enrollment begins in ASSENT 4 PCI trial

Nov. 13, 2003

Efficacy and safety of NO-aspirin demonstrated in mice and in healthy subjects

Nov. 13, 2003

Ajinomoto presents novel benzodiazepine-based factor Xa inhibitors

Nov. 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...